Browse Pharmaceutical industry topic

Licensing agreements subtopic

Articles 1-100 out of 100 article(s) Title Author Type Date Words Incyte Announces Major Collaboration and License Agreement for Two Hematology-Oncology Programs. Nov 25, 2009 1024 Appian Labs Announces Development and Commercial License Agreement with Capsugel for the AppiForm[TM] Modular Release System. Nov 17, 2009 548 BioInvent Signs Licensing Agreement with Daiichi Sankyo for the Discovery and Development of Therapeutic Antibodies. Nov 13, 2009 510 Flamel Technologies Announces Licensing Agreement with Pfizer. Nov 4, 2009 420 Ligand Updates License Agreement with Exelixis. Nov 2, 2009 537 SurModics and NuPathe Partner to Develop Novel Long-Acting Parkinson's Treatment. Nov 2, 2009 996 United States : Potentia Pharmaceuticals and Alcon Research sign license and purchase option agreements. Oct 24, 2009 415 Hercules Technology Growth Capital Announces Three Portfolio Companies That Reached Multi-Million Dollar Milestones. Oct 20, 2009 1149 United States: Orion Genomics Enters Discovery Collaboration and License Agreement to Advance Personalized Diagnostics. Oct 14, 2009 277 Mintz Levin Represents Paratek Pharmaceuticals, Inc. in $485M Licensing Agreement With Novartis. Oct 14, 2009 236 United States : Santarus and Norgine Enter License for ZEGERID Immediate-Release Omeprazole Products in Europe. Oct 12, 2009 277 Santarus and Norgine Enter License for ZEGERID Immediate-Release Omeprazole Products in Europe. Oct 12, 2009 974 Switzerland : Paratek, Novartis strike licensing deal. Oct 9, 2009 191 KYORIN and Eisai Sign License Agreement for Development and Marketing of Uritos(R) Tablets in China, India, Sri Lanka and ASEAN Countries. Sep 29, 2009 549 Eisai and DNDi Enter Collaboration and License Agreement to Develop New Drug for Chagas Disease. Sep 29, 2009 990 Kyorin and Eisai Sign License Agreement for Development and Marketing of Uritos(R) Tablets in China, India, Sri Lanka and ASEAN Countries. Sep 29, 2009 470 Rexahn Pharmaceuticals and Teva Pharmaceutical Industries Close on a License Agreement. Sep 21, 2009 505 Rexahn Pharmaceuticals and Teva Pharmaceutical Industries Agree to Close on a License Agreement. Sep 17, 2009 675 United States : Ceragenix Pharmaceuticals updates its license agreement for using CeraShield antimicrobial technology. Sep 1, 2009 247 Dyax Announces Developments in Licensing and Funded Research Program. Aug 26, 2009 1183 Nutra Pharma Announces Licensing Agreement with XenaCare Holdings to Market and Distribute Cobroxin, a Treatment for Chronic Pain. Aug 26, 2009 699 Germany : UCB, Novartis ink licensing deal for German mkt. Aug 24, 2009 160 United States : Santhera and Biovail Enter into License Agreement to Develop and Commercialize JP-1730/Fipamezole in North AmericaUnited States : Santhera and Biovail Enter into License Agreement to D. Aug 24, 2009 452 Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC-305. Aug 6, 2009 1250 Ligand and Organon Mutually Terminate Collaboration and License Agreement. Jul 30, 2009 655 South Africa : RECORDATI SIGNS A LICENSE AGREEMENT WITH PHARMAPLAN FOR SILODOSIN IN SOUTH AFRICA. Jul 30, 2009 474 Eisai Signs License Agreement with Biocompatibles International for Drug-Eluting Bead Products for Embolisation. Jul 28, 2009 634 Hercules Technology Growth Capital Announces Successful Fund Raising Activities from Select Life Sciences Portfolio Companies Despite Challenging Economy. Jul 27, 2009 877 Merck & Co., Inc. and Portola Enter Worldwide License Agreement to Develop and Commercialize Betrixaban, a Novel Investigational Oral Anticoagulant for Cardiovascular Disease. Jul 9, 2009 1150 Laboratorios SALVAT, S.A. and WraSer Pharmaceuticals, LLC Announce Exclusive License Agreement for the Commercialization of CETRAXAL[R] (ciprofloxacin otic solution) 0.2%. Jul 8, 2009 456 Rexahn Pharmaceuticals Signs Development and Commercialization Agreement with a Top 20 Pharmaceutical Company for Novel Anti-cancer Compound. Jun 29, 2009 624 Arrowhead Subsidiary Calando Pharmaceuticals Enters into License Agreement with Cerulean Pharma Inc. Jun 23, 2009 958 Cerulean Pharma Inc. Announces License Agreement with Calando Pharmaceuticals, Inc., a Subsidiary of Arrowhead Research Corporation. Jun 23, 2009 609 Gene Bridges Licenses Recombineering Technology to Chugai Pharmaceutical Co., Ltd. May 26, 2009 485 Pfizer Expands Its Generics Portfolio Through Innovative Licensing Deals, Increasing Access To Medicines For Billions Worldwide. May 20, 2009 873 Solvay Pharmaceuticals, Inc. Licenses Exclusive Development and Commercial Rights to Oral Testosterone Formulation from Lipocine Inc. May 19, 2009 501 SymBio Pharmaceuticals Limited and Eisai Co., Ltd. Conclude License Agreement for Bendamustine Hydrochloride (SyB L-0501) in Korea and Singapore. May 18, 2009 649 Biotech deals. Crowe, Deborah Brief article May 4, 2009 158 Biovail Enters into Collaboration and License Agreement with Acadia for Pimavanserin. May 4, 2009 1032 NextBio Announces Licensing Agreement with Merck & Co., Inc. Apr 27, 2009 267 Merck & Co., Inc., Medarex, Inc. and Massachusetts Biologic Laboratories Sign Exclusive Licensing Agreement for Investigational Monoclonal Antibody Combination for Clostridium Difficile Infection. Apr 21, 2009 1663 StemCells, Inc. Announces License Agreement with Major Pharmaceutical Company Covering Gene Insertion Technology. Apr 16, 2009 812 Merck & Co., Inc. and Santen Sign Licensing Agreement In Ophthalmology. Apr 15, 2009 679 SpePharm Announces a Claim in Excess of 35 Million Euros Against BioAlliance Pharma For Breaking up Their Joint-Venture SpeBio. Apr 14, 2009 668 Merck & Co., Inc. and Cardiome Sign License Agreement for Vernakalant, an Investigational Drug for Treatment of Atrial Fibrillation. Apr 8, 2009 1624 Research and Markets: Evolving Trends in Biopharmaceutical Licensing - Deal Assessments, Drivers and Resistors. Apr 6, 2009 869 Eisai and Nobelpharma Sign License Agreement for GLIADEL(R) WAFER in Japan. Apr 6, 2009 711 Alnara Pharmaceuticals Licenses Worldwide Rights to Liprotamase from Cystic Fibrosis Foundation. Mar 25, 2009 1193 Teikoku Pharma USA and Eisai Co., Ltd Announce Licensing Agreement for a New 7-Day Transdermal Formulation of donepezil. Mar 10, 2009 306 Lee's Pharmaceutical Enters into Agreement with Nippon Shinyaku, a Move To Accelerate Market Diversification in China. Mar 4, 2009 449 Lee's Pharmaceutical Enters into Agreement with Nippon Shinyaku, a Move To Accelerate Market Diversification in China. Mar 3, 2009 443 Pfizer Expands Portfolio of Generic Medicines in the U.S. and Europe Through Licensing Agreements with Aurobindo. Mar 3, 2009 465 Lee's Pharmaceutical Enters into Agreement with Nippon Shinyaku, a Move To Accelerate Market Diversification in China. Mar 3, 2009 445 Xencor and Pfizer Enter into Antibody Technology Licensing Agreement. Mar 2, 2009 596 Research and Markets: Essential Guide to Valuation of Pharmaceutical Licensing Deals for Maximising Deal Values and Minimising Risk. Mar 2, 2009 195 Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International. Mar 1, 2009 208 Ligand Pharmaceuticals and The Rockefeller University Enter Settlement Agreement and Mutual Release. Feb 12, 2009 810 Acacia Subsidiary Enters into License Agreement with Johnson & Johnson. Feb 12, 2009 321 Hercules Technology's Portfolio Company, Portola Pharmaceuticals, Has Entered Into a Worldwide License Agreement With Novartis. Feb 12, 2009 878 BioAlliance Pharma: 2008 Consolidated Turnover: +134%. Feb 10, 2009 818 Singapore : S BIO and Tragara Pharmaceuticals sign licensing agreement. Jan 23, 2009 237 Lab deal: Iris International Inc. Mendoza, Lauren Alicia Brief article Jan 19, 2009 56 Merrion lands e58m licence agreement. Jan 17, 2009 84 Germany : Micromet signs licensing agreement with Bayer Schering Pharma. Jan 15, 2009 273 United States : Watson and Warner Chilcott sign settlement and licensing agreements. Jan 15, 2009 323 Canada : Stellar signs licensing agreement with EuroCept. Jan 13, 2009 215 Depomed's License Agreement With Solvay Pharmaceuticals Clears HSR Review. Jan 6, 2009 1076 United states : Ligand signs licensing agreement with GlaxoSmithKline. Dec 24, 2008 219 Ligand Enters into Exclusive License Agreement with GlaxoSmithKline to License Rights to LGD-4665 and other Ligand Thrombopoietin (TPO) Molecules. Dec 18, 2008 685 Enigma Diagnostics Announces Term Sheet for PCR Patent Licenses with Roche. Dec 1, 2008 395 Covidien and Depomed Announce License Agreement. Nov 24, 2008 887 Depomed, Inc. Announces Conference Call to Discuss Exclusive North American License Agreement with Solvay Pharmaceuticals, Inc. Nov 21, 2008 321 Solvay Pharmaceuticals, Inc. Announces Exclusive North American License Agreement with Depomed, Inc. for Gabapentin GR[R] for the Treatment of Neuropathic Pain. Nov 20, 2008 1094 Depomed, Inc. Announces Exclusive North American License Agreement with Solvay Pharmaceuticals, Inc. for DM-1796 (Gabapentin GR[R]) in the Treatment of Pain. Nov 20, 2008 1245 Denmark: Antyra signs licensing agreement with Novo Nordisk. Nov 15, 2008 168 Israel: BioLineRx and Yissum sign licensing agreement. Nov 15, 2008 143 United States: Marillion and Bracco Imaging sign licensing agreement. Nov 15, 2008 143 Antyra Enters into Licensing Agreement for Anticancer Agents from Novo Nordisk A/S. Nov 12, 2008 629 BioLineRx and Yissum Sign a Licensing Agreement for the Development of a Novel Compound for the Treatment of Inflammatory Bowel Disease. Nov 12, 2008 819 Marillion Pharmaceuticals and Bracco Imaging S.p.A. Announce License Agreement to Develop and Commercialize Novel Cancer Treatment. Nov 11, 2008 721 Profectus BioSciences Executes an Assignment and License Agreement with Wyeth for Vaccines against HIV, HCV, HPV and HSV. Nov 10, 2008 351 Winston Laboratories, Inc. Announces Licensing Agreement with sanofi-aventis Canada Inc. in Canada. Nov 7, 2008 755 Taiwan: Cel-Sci expands licensing agreement with Orient Europharma. Nov 7, 2008 212 Unilife signs exclusive agreement with Sanofi-Aventis. Nov 1, 2008 200 United States: Aires Pharmaceuticals signs technology license agreement with NIH. Oct 24, 2008 168 United States: Progenics signs licensing agreement with Ono Pharmaceutical. Oct 20, 2008 227 Elixir Medical Corporation Licenses Myolimus(TM) From Novartis Pharma AG for Site-Specific Drug Delivery Applications. Oct 10, 2008 612 Switzerland: Oncalis signs licensing agreement with ChemDiv. Oct 9, 2008 227 United States: Lilly signs licensing and collaboration agreement with Deciphera. Oct 8, 2008 228 United States: Three Rivers pharmaceuticals signs licensing agreement with Amgen. Sep 22, 2008 180 United States: Signum biosciences signs investment and licensing agreements with Rohto. Sep 22, 2008 189 United States: EpiCept amends bupivacaine patch licensing agreement with Durect. Sep 17, 2008 133 EpiCept Amends DURECT Bupivacaine Patch Licensing Agreement. Sep 15, 2008 869 Korea: AmpliMed signs licensing agreement with Handok Pharmaceuticals. Sep 13, 2008 300 AmpliMed Announces License Agreement with Handok Pharmaceuticals for Exclusive Rights to Cancer Therapeutic Amplimexon(R) in Korea. Sep 10, 2008 559 Canopus BioPharma Strengthens its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement With Wisconsin Alumni Research Foundation. Jun 1, 2008 519 EUSA Pharma out-licenses preclinical-stage human antibody to GSK. Brief article Mar 1, 2008 289 Pfizer Inc. (NYSE:PFE) and Scil Technology GmbH (Scil) have signed a licensing agreement for worldwide collaboration on Scil's cartilage specific growth factor CD-RAP. Brief article Jan 1, 2008 213 Agreements. Aug 1, 2005 783 Agreements. Jan 1, 2004 781